The University of Chicago Header Logo

Connection

Kathleen Mullane to Survival Rate

Back to Details
This is a "connection" page, showing publications Kathleen Mullane has written about Survival Rate.
Kathleen Mullane
Connection Strength
0.031
Survival Rate
  1. A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 02; 25(2):369-381.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.